278 related articles for article (PubMed ID: 15787744)
1. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
2. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
[TBL] [Abstract][Full Text] [Related]
3. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M
J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450
[TBL] [Abstract][Full Text] [Related]
5. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities.
Stepkowski SM; Tu Y; Condon TP; Bennett CF
J Immunol; 1994 Dec; 153(11):5336-46. PubMed ID: 7963586
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
Ferraresso M; Tian L; Ghobrial R; Stepkowski SM; Kahan BD
J Immunol; 1994 Oct; 153(7):3307-18. PubMed ID: 8089500
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
Stepkowski SM; Tu Y; Chou TC; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
[No Abstract] [Full Text] [Related]
9. Donor-specific unresponsiveness to murine cardiac allografts induced by intrathymic-soluble alloantigens is dependent on alternate pathway of antigen presentation.
Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
J Surg Res; 1995 Jul; 59(1):91-6. PubMed ID: 7630143
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival without posttransplant immunosuppression in a large animal model.
Granger DK; Matas AJ; Jenkins MK; Moss AA; Chen SC; Almond PS
Surgery; 1994 Aug; 116(2):236-41. PubMed ID: 8047990
[TBL] [Abstract][Full Text] [Related]
11. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
Tu Y; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
[TBL] [Abstract][Full Text] [Related]
12. Acute rejection of vascular heart allografts by perforin-deficient mice.
Schulz M; Schuurman HJ; Joergensen J; Steiner C; Meerloo T; Kägi D; Hengartner H; Zinkernagel RM; Schreier MH; Bürki K
Eur J Immunol; 1995 Feb; 25(2):474-80. PubMed ID: 7533086
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses.
Wolos JA; Frondorf KA; Babcock GF; Stripp SA; Bowlin TL
Cell Immunol; 1993 Jul; 149(2):402-8. PubMed ID: 8330316
[TBL] [Abstract][Full Text] [Related]
14. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion.
Gorczynski RM; Wojcik D
J Immunol; 1994 Feb; 152(4):2011-9. PubMed ID: 7907109
[TBL] [Abstract][Full Text] [Related]
15. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10.
Qin L; Chavin KD; Ding Y; Favaro JP; Woodward JE; Lin J; Tahara H; Robbins P; Shaked A; Ho DY
Transplantation; 1995 Mar; 59(6):809-16. PubMed ID: 7701573
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rapamycin, RS-61443 and cyclophosphamide in the prolongation of survival of discordant pig to rabbit cardiac xenografts.
Yatscoff RW; Wang S; Keenan R; Chackowsky P; Lowes N; Koshal A
Can J Cardiol; 1994 Sep; 10(7):711-6. PubMed ID: 7922826
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin: immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model.
Almond PS; Moss A; Nakhleh RE; Melin M; Chen S; Salazar A; Shirabe K; Matas AJ
Transplantation; 1993 Aug; 56(2):275-81. PubMed ID: 8356580
[TBL] [Abstract][Full Text] [Related]
18. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
[No Abstract] [Full Text] [Related]
19. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates.
Bashuda H; Kimikawa M; Seino K; Kato Y; Ono F; Shimizu A; Yagita H; Teraoka S; Okumura K
J Clin Invest; 2005 Jul; 115(7):1896-902. PubMed ID: 15951837
[TBL] [Abstract][Full Text] [Related]
20. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
Isobe M; Ihara A
Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
